Home > Insider Trading > Filing (0001595585-21-000145)

Filing Details

Accession Number:: 0001595585-21-000145
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-10 16:33:16
Reporting Period:: 2021-12-08

Accepted Time:: 2021-12-10 16:33:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1595585	Tricida Inc.	TCDA	Pharmaceutical Preparations (2834)	463372526

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1744280	I Sandra Coufal	7000 Shoreline Court Suite 201 South San Francisco CA 94080		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-12-08	500	$8.00	109,993	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,860	Indirect	By Coufal Irrevocable Trust
Common Stock	777,411	Indirect	By Sibling Capital Fund II-A L.P.
Common Stock	2,773,350	Indirect	By Sibling Capital Fund II-B L.P.
Common Stock	1,810,195	Indirect	By Sibling Capital Fund II-C L.P.
Common Stock	599,379	Indirect	By Sibling Capital Fund II-D L.P.
Common Stock	463,158	Indirect	By Sibling Insiders Fund II L.P.

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2020.
The spouse of the Reporting Person is the sole trustee of the Coufal Irrevocable Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Coufal Irrevocable Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person disclaims beneficial ownership of any such securities, except to the extent of pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
The shares are held directly by Sibling Capital Fund II-A L.P. ("Sibling A"). Sibling Capital Ventures LLC ("SCV") is the sole general partner of Sibling A. As co-manager of SCV, Sandra I. Coufal may be deemed to be an indirect beneficial owner of such shares.
The shares are held directly by Sibling Capital Fund II-B L.P. ("Sibling B"). Sibling Capital Ventures II LLC ("SCV II") is the sole general partner of Sibling B. As co-manager of SCV II, Sandra I. Coufal may be deemed to be an indirect beneficial owner of such shares.
The shares are held directly by Sibling Capital Fund II-C L.P. ("Sibling C"). Sibling Capital Ventures III LLC ("SCV III") is the sole general partner of Sibling C. As co-manager of SCV III, Sandra I. Coufal may be deemed to be an indirect beneficial owner of such shares.
The shares are held directly by Sibling Capital Fund II-D L.P. ("Sibling D"). Sibling Capital Ventures IV LLC ("SCV IV") is the sole general partner of Sibling D. As co-manager of SCV IV, Sandra I. Coufal may be deemed to be an indirect beneficial owner of such shares.
The shares are held directly by Sibling Insiders Fund II L.P. ("Sibling Insiders Fund"). Sibling Insiders II LLC ("Sibling Insiders LLC") is the sole general partner of Sibling Insiders Fund. As co-manager of Sibling Insiders LLC, Sandra I. Coufal may be deemed to be an indirect beneficial owner of such shares.